Alzheimers Disease Antibodies

Product description

The Competitive Intelligence Report Alzheimer's Disease Antibodies as of July 2008 provides a competitor analysis in the development pipeline of novel antibodies for passive immunotherapy of Alzheimers disease including those targeting amyloid-beta (beta-amyloid). Among the companies active in the field of new antibodies for passive immunotherapy of Alzheimers disease Wyeth, Elan, Pfizer, Roche and many others.

The report includes a compilation of current active projects in research and development of novelantibodies for passive immunotherapy of Alzheimers disease.

Competitor projects are listed in a tabular format providing Information on:

• Drug Codes,
• Target / Mechanism of Action,
• Class of Compound,
• Company,
• Product category,
• Indication,
• R&D Stage and
• additional comments with a hyperlink leading to the source of information.